Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner

Brain Research

Volumn 1345, Issue , 2010, Pages 176-181

  Zhang, Zhang ^a   Simpkins, James W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Alzheimer's disease; cdk5; Estrogen; Phosphatase; Tau

Indexed keywords

BETA ACTIN; CYCLIN DEPENDENT KINASE 5; ESTRADIOL; ESTROGEN; FULVESTRANT; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; TAU PROTEIN; ANTIESTROGEN; CDK5 PROTEIN, HUMAN; ENZYME INHIBITOR; ESTROGEN RECEPTOR; MAPT PROTEIN, HUMAN; NERVE PROTEIN; P25 PROTEIN, HUMAN; PHOSPHOPROTEIN PHOSPHATASE;

ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HORMONAL REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; FEMALE; METABOLISM; NERVE CELL; PHOSPHORYLATION; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 5; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMANS; NERVE TISSUE PROTEINS; NEURONS; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; RECEPTORS, ESTROGEN; TAU PROTEINS; UP-REGULATION;

EID: 77955516619     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.074     Document Type: Article

References (47)

1. A.C. Alonso, I. Grundke-Iqbal, and K. Iqbal Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules Nat. Med. 2 1996 783 787
2. M. Alvarez-de-la-Rosa, I. Silva, J. Nilsen, M.M. Perez, L.M. Garcia-Segura, J. Avila, and F. Naftolin Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease Ann. N. Y. Acad. Sci. 1052 2005 210 224
3. T. Arendt, M. Holzer, M.K. Bruckner, C. Janke, and U. Gartner The use of okadaic acid in vivo and the induction of molecular changes typical for Alzheimer's disease Neuroscience 85 1998 1337 1340
4. C. Arias, N. Sharma, P. Davies, and B. Shafit-Zagardo Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons J. Neurochem. 61 1993 673 682
5. J. Avila, J.J. Lucas, M. Perez, and F. Hernandez Role of tau protein in both physiological and pathological conditions Physiol. Rev. 84 2004 361 384
6. C. Ballatore, V.M. Lee, and J.Q. Trojanowski Tau-mediated neurodegeneration in Alzheimer's disease and related disorders Nat. Rev. Neurosci. 8 2007 663 672
7. O.Y. Bang, H.S. Hong, D.H. Kim, H. Kim, J.H. Boo, K. Huh, and I. Mook-Jung Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity Neurobiol. Dis. 16 2004 21 28
8. J. Baudier, and R.D. Cole Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids J. Biol. Chem. 262 1987 17577 17583
9. I. Correas, J. Diaz-Nido, and J. Avila Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain J. Biol. Chem. 267 1992 15721 15728
10. F. Devred, P. Barbier, S. Douillard, O. Monasterio, J.M. Andreu, and V. Peyrot Tau induces ring and microtubule formation from alphabeta-tubulin dimers under nonassembly conditions Biochemistry 43 2004 10520 10531
11. G. Drewes, B. Lichtenberg-Kraag, F. Doring, E.M. Mandelkow, J. Biernat, J. Goris, M. Doree, and E. Mandelkow Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state EMBO J. 11 1992 2131 2138
12. M.W. Dudley, C.Q. Sheeler, H. Wang, and S. Khan Activation of the human estrogen receptor by the antiestrogens ICI 182, 780 and tamoxifen in yeast genetic systems: implications for their mechanism of action Proc. Natl. Acad. Sci. U. S. A. 97 2000 3696 3701
13. F.J. Ekinci, and T.B. Shea Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities Cell. Mol. Neurobiol. 19 1999 249 260
14. F.J. Ekinci, D. Ortiz, and T.B. Shea Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel Brain Res. Mol. Brain Res. 117 2003 145 151
15. C.M. Filley Alzheimer's disease in women Am. J. Obstet. Gynecol. 176 1997 1 7
16. M. Goedert, M.G. Spillantini, R. Jakes, D. Rutherford, and R.A. Crowther Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease Neuron 3 1989 519 526
17. C.X. Gong, T.J. Singh, I. Grundke-Iqbal, and K. Iqbal Phosphoprotein phosphatase activities in Alzheimer disease brain J. Neurochem. 61 1993 921 927
18. C.X. Gong, S. Shaikh, J.Z. Wang, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain J. Neurochem. 65 1995 732 738
19. C.X. Gong, T. Lidsky, J. Wegiel, L. Zuck, I. Grundke-Iqbal, and K. Iqbal Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease J. Biol. Chem. 275 2000 5535 5544
20. C.X. Gong, F. Liu, I. Grundke-Iqbal, and K. Iqbal Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target J. Biomed. Biotechnol. 2006 2006 31825
21. P.S. Green, and J.W. Simpkins Neuroprotective effects of estrogens: potential mechanisms of action Int. J. Dev. Neurosci. 18 2000 347 358
22. C.A. Grimes, and R.S. Jope The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog. Neurobiol. 65 2001 391 426
23. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y.C. Tung, M.S. Zaidi, and H.M. Wisniewski Microtubule-associated protein tau. A component of Alzheimer paired helical filaments J. Biol. Chem. 261 1986 6084 6089
24. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski, and L.I. Binder Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc. Natl. Acad. Sci. U. S. A. 83 1986 4913 4917
25. D.P. Hanger, K. Hughes, J.R. Woodgett, J.P. Brion, and B.H. Anderton Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase Neurosci. Lett. 147 1992 58 62
26. V.W. Henderson, A. Paganini-Hill, C.K. Emanuel, M.E. Dunn, and J.G. Buckwalter Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects Arch. Neurol. 51 1994 896 900
27. F. Hernandez, and J. Avila Tauopathies Cell. Mol. Life Sci. 64 2007 2219 2233
28. Y. Ihara, N. Nukina, R. Miura, and M. Ogawara Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease J. Biochem. 99 1986 1807 1810
29. K. Ishiguro, M. Takamatsu, K. Tomizawa, A. Omori, M. Takahashi, M. Arioka, T. Uchida, and K. Imahori Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments J. Biol. Chem. 267 1992 10897 10901
30. K. Ishiguro, A. Shiratsuchi, S. Sato, A. Omori, M. Arioka, S. Kobayashi, T. Uchida, and K. Imahori Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments FEBS Lett. 325 1993 167 172
31. G.V. Johnson, and W.H. Stoothoff Tau phosphorylation in neuronal cell function and dysfunction J. Cell Sci. 117 2004 5721 5729
32. G. Lace, G.M. Savva, G. Forster, R. de Silva, C. Brayne, F.E. Matthews, J.J. Barclay, L. Dakin, P.G. Ince, S.B. Wharton MRC-CFAS Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study Brain 132 2009 1324 1334
33. M.S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander, and L.H. Tsai Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 2000 360 364
34. C.F. Lin, C.L. Chen, C.W. Chiang, M.S. Jan, W.C. Huang, and Y.S. Lin GSK-3beta acts downstream of PP2A and the PI 3-kinase-akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis J. Cell Sci. 120 2007 2935 2943
35. F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation Eur. J. Neurosci. 22 2005 1942 1950
36. M. Liu, S. Choi, G.D. Cuny, K. Ding, B.C. Dobson, M.A. Glicksman, K. Auerbach, and R.L. Stein Kinetic studies of Cdk5/p25 kinase: phosphorylation of tau and complex inhibition by two prototype inhibitors Biochemistry 47 2008 8367 8377
37. M.P. Mazanetz, and P.M. Fischer Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases Nat. Rev. Drug Discov. 6 2007 464 479
38. A. Paganini-Hill, and V.W. Henderson Estrogen deficiency and risk of Alzheimer's disease in women Am. J. Epidemiol. 140 1994 256 261
39. N. Sergeant, A. Delacourte, and L. Buee Tau protein as a differential biomarker of tauopathies Biochim. Biophys. Acta 1739 2005 179 197
40. M. Singh, J.A. Dykens, and J.W. Simpkins Novel mechanisms for estrogen-induced neuroprotection Exp. Biol. Med. (Maywood) 231 2006 514 521
41. E. Sontag, A. Luangpirom, C. Hladik, I. Mudrak, E. Ogris, S. Speciale, and C.L. White III Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology J. Neuropathol. Exp. Neurol. 63 2004 287 301
42. T. Uchida, K. Ishiguro, J. Ohnuma, M. Takamatsu, S. Yonekura, and K. Imahori Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: its sequence and developmental change in brain FEBS Lett. 355 1994 35 40 (Pubitemid 24352098)
43. V. Vogelsberg-Ragaglia, T. Schuck, J.Q. Trojanowski, and V.M. Lee PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus Exp. Neurol. 168 2001 402 412
44. M.D. Weingarten, A.H. Lockwood, S.Y. Hwo, and M.W. Kirschner A protein factor essential for microtubule assembly Proc. Natl. Acad. Sci. U. S. A. 72 1975 1858 1862
45. K.D. Yi, D.F. Covey, and J.W. Simpkins Mechanism of okadaic acid-induced neuronal death and the effect of estrogens J. Neurochem. 108 2009 732 740
46. S. Yoon, J. Choi, J.W. Huh, O. Hwang, and D. Kim Calpain activation in okadaic-acid-induced neurodegeneration NeuroReport 17 2006 689 692
47. Z. Zhang, and J.W. Simpkins Okadaic acid induces cognitive deficiency in rats Society for Neuroscience Abstract No. 556.4/BB25 2008